MDR 1.72% 29.5¢ medadvisor limited

Ann: MDR H1 FY2018 Financial Report & Appendix 4D, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,108 Posts.
    lightbulb Created with Sketch. 84
    International Expansion
    The evaluation phases are well progressed, and the Company looks forward to providing an update to the market when appropriate.

    Corporate update
    MedAdvisor and EBOS Group Limited entered into a number of commercial agreements to enable MedAdvisor to leverage EBOS’ healthcare portfolio to drive customer acquisition and new revenue opportunities. The Company continues to work closely with all parties to sign formal binding agreements, which will be announced to the market in due course.


    Outlook
    MedAdvisor has a significant opportunity for expansion within the hospital channel. The Company is now developing a hospital admission and discharge product and process that will leverage MedAdvisor’s capabilities to connect with their primary healthcare providers and help patients increase their adherence.


    Despite the lack of updates it sounds like they have been very busy over the last 4 months.

    I'm also reading between the lines and seeing that initial scope with EBOS has grown.

    I like the statement under International Expansion suggesting product elements are being evaluated.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $215.0M
Open High Low Value Volume
29.0¢ 29.5¢ 27.5¢ $248.7K 869.1K

Buyers (Bids)

No. Vol. Price($)
3 24636 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 13888 2
View Market Depth
Last trade - 15.28pm 15/11/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.